Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Syndax Pharmaceuticals SNDX Stock Price Movement Behavior Q4 2025 Earnings Underperform What volume drop Cathay Bancorp CATY Buying Pressure 20260501 What Five Star FSBC accounting reveals about the business FSBC Five Star Beats Q1 Forecasts Posts 84 EPS Surprise XNET Xunlei posts Q3 2024 earnings of 008 dollar per share stock registers no price change today Inflation Pressures Intensify Ahead of Memorial Day Weekend as Prices Surge for Travel Food and Fuel Twilio Form 144 Filing Signals Potential Insider Share Sale Bessent Predicts Substantial Disinflation as Warsh Poised to Lead Fed The Week Highlights Potential AI IPO Race Among SpaceX Anthropic and OpenAI Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday White House Ceremony Planned Space Stocks Rally on Renewed SpaceX IPO Speculation Indaptus Therapeutics Q4 2025 Earnings EPS Miss Amid Continued RD Investment ADAMZ Q1 2026 Earnings Strong EPS Beat of 75 Despite Flat Revenue and Share Price Dip Danaos Corporation Q1 2026 Earnings Slight EPS Miss Despite Solid Operations RFIL Q1 2026 Earnings Strong EPS Surprise Drives Share Gains Despite Limited Revenue Disclosure HOVR Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Focuses on Development Sprinklr Inc CXM Q1 2026 Earnings Earnings Beat Drives Optimism Despite Slight Stock Dip Asure Software ASUR Slips 125 as Stock Tests Key Support Zone Perion Network PERI Tests Key Support After 36 Decline Lionheart Holdings Unit CUBWU Holds Steady at 1085 as Market Awaits Catalyst HNI Corporation HNI Edges Lower as Stock Consolidates Near Support Glacier Bancorp GBCI Jumps Nearly 2 as Shares Approach Key Resistance Level SuRo Capital Holds Steady Near Support as Price Edges Higher Gain Therapeutics GANX Climbs Higher as Bullish Momentum Builds Near Resistance Praxis Precision Medicines PRAX Holds Near Resistance After Slight Pullback Nu Skin Enterprises NUS Rebounds 37 as It Tests Key Resistance Zone Ernexa Therapeutics ERNA Slides 25 as Weakness Persists Near Support Levels